Dapagliflozin and Metformin Hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
42571-321 -
Package NDC
42571-321-05 -
Package NDC
42571-321-30 -
Package NDC
42571-321-90 -
Application number
ANDA211466 -
SPL ID
4f01ca78-24ac-c371-e063-6294a90a021c -
SPL set ID
10aa7cc4-4f9a-4403-a5c0-753d2aa5f0f9 -
UNII
1ULL0QJ8UC -
UNII
786Z46389E -
RxCUI
1593058 -
RxCUI
1593068 -
RxCUI
1593070 -
RxCUI
1593072
What the source publishes
- Labeler
- Micro Labs Limited
- Active ingredients
- Dapagliflozin and Metformin Hydrochloride
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Dapagliflozin and Metformin Hydrochloride",
"splId": "4f01ca78-24ac-c371-e063-6294a90a021c",
"labels": [
{
"setId": "10aa7cc4-4f9a-4403-a5c0-753d2aa5f0f9",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10aa7cc4-4f9a-4403-a5c0-753d2aa5f0f9",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=10aa7cc4-4f9a-4403-a5c0-753d2aa5f0f9"
}
],
"routes": [
"ORAL"
],
"labeler": "Micro Labs Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42571-321-05)",
"package_ndc": "42571-321-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20261001"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42571-321-30)",
"package_ndc": "42571-321-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20261001"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (42571-321-90)",
"package_ndc": "42571-321-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20261001"
}
],
"productId": "42571-321_4f01ca78-24ac-c371-e063-6294a90a021c",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED, EXTENDED RELEASE",
"productNdc": "42571-321",
"deaSchedule": null,
"genericName": "Dapagliflozin and Metformin Hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "DAPAGLIFLOZIN",
"strength": "10 mg/1"
},
{
"name": "METFORMIN HYDROCHLORIDE",
"strength": "500 mg/1"
}
],
"applicationNumber": "ANDA211466",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20261001",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000187059",
"N0000187058"
],
"upc": [
"0342571321307",
"0342571320300",
"0342571323301",
"0342571322601"
],
"unii": [
"1ULL0QJ8UC",
"786Z46389E"
],
"rxcui": [
"1593058",
"1593068",
"1593070",
"1593072"
],
"spl_set_id": [
"10aa7cc4-4f9a-4403-a5c0-753d2aa5f0f9"
],
"pharm_class_epc": [
"Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
],
"pharm_class_moa": [
"Sodium-Glucose Transporter 2 Inhibitors [MoA]"
],
"manufacturer_name": [
"Micro Labs Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:42571-321_4f01ca78-24ac-c371-e063-6294a90a021c"